NYSE:GMRE - Global Medical REIT Stock Price, Forecast & News

Global Medical REIT trades on the New York Stock Exchange (NYSE) under the ticker symbol "GMRE."

Global Medical REIT declared a quarterly dividend on Monday, December 16th. Investors of record on Thursday, December 26th will be paid a dividend of $0.20 per share on Thursday, January 9th. This represents a $0.80 dividend on an annualized basis and a yield of 5.05%. The ex-dividend date is Tuesday, December 24th. View Global Medical REIT's Dividend History.

Global Medical REIT Inc (NYSE:GMRE) announced its quarterly earnings data on Wednesday, November, 6th. The company reported $0.02 earnings per share for the quarter, missing the consensus estimate of $0.19 by $0.17. The company had revenue of $18.20 million for the quarter, compared to analysts' expectations of $17.68 million. Global Medical REIT had a net margin of 23.42% and a return on equity of 5.49%. View Global Medical REIT's Earnings History.

Global Medical REIT is scheduled to release their next quarterly earnings announcement on Wednesday, March 4th 2020. View Earnings Estimates for Global Medical REIT.

Global Medical REIT will be holding an earnings conference call on Wednesday, March 4th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

5 equities research analysts have issued twelve-month target prices for Global Medical REIT's stock. Their forecasts range from $11.00 to $16.00. On average, they expect Global Medical REIT's stock price to reach $14.10 in the next twelve months. This suggests that the stock has a possible downside of 11.0%. View Analyst Price Targets for Global Medical REIT.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Global Medical REIT in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Global Medical REIT.

Media stories about GMRE stock have been trending somewhat positive this week, according to InfoTrie. The research firm identifies positive and negative media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Global Medical REIT earned a news sentiment score of 2.0 on InfoTrie's scale. They also gave news stories about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the stock's share price in the near term. View News Stories for Global Medical REIT.

Some companies that are related to Global Medical REIT include Great Portland Estates (GPEAF), Hammerson (HMSNF), Ladder Capital (LADR), Four Corners Property Trust (FCPT), Caretrust REIT (CTRE), Acadia Realty Trust (AKR), National Storage Affiliates Trust (NSA), Uniti Group (UNIT), DiamondRock Hospitality (DRH), The GEO Group (GEO), Corecivic (CXW), Redwood Trust (RWT), Retail Opportunity Investments (ROIC), Mack Cali Realty (CLI) and LTC Properties (LTC).

Based on aggregate information from My MarketBeat watchlists, some companies that other Global Medical REIT investors own include Principal Financial Group (PFG), Insys Therapeutics (INSY), General Electric (GE), Big Lots (BIG), Square (SQ), New Residential Investment (NRZ), Ready Capital (RC), Cypress Semiconductor (CY), Sangamo Therapeutics (SGMO) and Ritter Pharmaceuticals (RTTR).

(GMRE) raised $130 million in an initial public offering on Wednesday, June 29th 2016. The company issued 13,000,000 shares at a price of $10.00 per share. Wunderlich and Oppenheimer served as the underwriters for the IPO and BB&T Capital Markets, Compass Point and D.A. Davidson were co-managers.

Global Medical REIT's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Psagot Investment House Ltd. (2.65%), Prudential Financial Inc. (2.59%), Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet LTD (2.51%), State Street Corp (2.14%), FMR LLC (2.00%) and RMR Advisors LLC (1.45%). Company insiders that own Global Medical REIT stock include Jeffrey Busch, Matthew Cypher, Ronald Marston, Roscoe M Moore Jr and Zh Usa, Llc. View Institutional Ownership Trends for Global Medical REIT.

GMRE stock was sold by a variety of institutional investors in the last quarter, including Marshall Wace LLP, Pacific Ridge Capital Partners LLC, Chicago Equity Partners LLC, EAM Investors LLC, Foundry Partners LLC, AXA, Victory Capital Management Inc. and Eidelman Virant Capital. View Insider Buying and Selling for Global Medical REIT.

GMRE stock was acquired by a variety of institutional investors in the last quarter, including Prudential Financial Inc., FMR LLC, Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet LTD, Psagot Investment House Ltd., Bullseye Asset Management LLC, Dana Investment Advisors Inc., Meitav Dash Investments Ltd. and HGI Capital Management LLC. Company insiders that have bought Global Medical REIT stock in the last two years include Jeffrey Busch, Matthew Cypher, Ronald Marston and Zh Usa, Llc. View Insider Buying and Selling for Global Medical REIT.

Shares of GMRE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of GMRE stock can currently be purchased for approximately $15.85.

Global Medical REIT has a market capitalization of $584.39 million and generates $53.19 million in revenue each year. The company earns $13.49 million in net income (profit) each year or $0.78 on an earnings per share basis. View Additional Information About Global Medical REIT.

The official website for Global Medical REIT is http://www.globalmedicalreit.com/.

Global Medical REIT's mailing address is 2 Bethesda Metro Center Suite 440, BETHESDA MD, 20814. The company can be reached via phone at 202-524-6851.